A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics

Abstract Background This study aimed to classify the distinct group of patients with axial spondyloarthritis (SpA) on tumour necrosis factor alpha inhibitors (TNFi) according to the baseline characteristics using a clustering algorithm. Methods The clinical characteristics and demographic data of pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seulkee Lee, Seonyoung Kang, Yeonghee Eun, Hong-Hee Won, Hyungjin Kim, Hoon-Suk Cha, Eun-Mi Koh, Jaejoon Lee
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
TNF
Acceso en línea:https://doaj.org/article/dafb7014795240c296d53e36484abd95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dafb7014795240c296d53e36484abd95
record_format dspace
spelling oai:doaj.org-article:dafb7014795240c296d53e36484abd952021-11-21T12:03:45ZA cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics10.1186/s13075-021-02647-z1478-6362https://doaj.org/article/dafb7014795240c296d53e36484abd952021-11-01T00:00:00Zhttps://doi.org/10.1186/s13075-021-02647-zhttps://doaj.org/toc/1478-6362Abstract Background This study aimed to classify the distinct group of patients with axial spondyloarthritis (SpA) on tumour necrosis factor alpha inhibitors (TNFi) according to the baseline characteristics using a clustering algorithm. Methods The clinical characteristics and demographic data of patients with axial SpA included in the Korean College of Rheumatology Biologics and Targeted Therapy registry were investigated. The patterns of disease manifestations were examined using divisive hierarchical cluster analysis. After clustering, we compared the clinical characteristics of patients and the drug survival of TNFi between the classified groups. Results A total of 1042 patients were analysed. The cluster analysis classified patients into two groups: axial group predominantly showing isolated axial manifestations (n = 828) and extra-axial group more frequently showing extra-axial symptoms (n = 214). Almost all extra-axial symptoms (peripheral arthritis, enthesitis, uveitis, and psoriasis) were more frequently observed in the extra-axial group than in the axial group. Moreover, patients in the extra-axial group had shorter disease duration, later disease onset, and higher disease activity than those in the axial group. The disease activity was comparable between the two groups after 1 year of treatment with TNFi. Interestingly, the extra-axial group had a lower drug survival with TNFi than the axial group (p = 0.001). Conclusions Cluster analysis of patients with axial SpA using TNFi classified two distinct clinical phenotypes. These clusters had different TNFi drug survival, clinical characteristics, and disease activity.Seulkee LeeSeonyoung KangYeonghee EunHong-Hee WonHyungjin KimHoon-Suk ChaEun-Mi KohJaejoon LeeBMCarticleSpondyloarthritisTNFCluster analysisDrug survivalDiseases of the musculoskeletal systemRC925-935ENArthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Spondyloarthritis
TNF
Cluster analysis
Drug survival
Diseases of the musculoskeletal system
RC925-935
spellingShingle Spondyloarthritis
TNF
Cluster analysis
Drug survival
Diseases of the musculoskeletal system
RC925-935
Seulkee Lee
Seonyoung Kang
Yeonghee Eun
Hong-Hee Won
Hyungjin Kim
Hoon-Suk Cha
Eun-Mi Koh
Jaejoon Lee
A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
description Abstract Background This study aimed to classify the distinct group of patients with axial spondyloarthritis (SpA) on tumour necrosis factor alpha inhibitors (TNFi) according to the baseline characteristics using a clustering algorithm. Methods The clinical characteristics and demographic data of patients with axial SpA included in the Korean College of Rheumatology Biologics and Targeted Therapy registry were investigated. The patterns of disease manifestations were examined using divisive hierarchical cluster analysis. After clustering, we compared the clinical characteristics of patients and the drug survival of TNFi between the classified groups. Results A total of 1042 patients were analysed. The cluster analysis classified patients into two groups: axial group predominantly showing isolated axial manifestations (n = 828) and extra-axial group more frequently showing extra-axial symptoms (n = 214). Almost all extra-axial symptoms (peripheral arthritis, enthesitis, uveitis, and psoriasis) were more frequently observed in the extra-axial group than in the axial group. Moreover, patients in the extra-axial group had shorter disease duration, later disease onset, and higher disease activity than those in the axial group. The disease activity was comparable between the two groups after 1 year of treatment with TNFi. Interestingly, the extra-axial group had a lower drug survival with TNFi than the axial group (p = 0.001). Conclusions Cluster analysis of patients with axial SpA using TNFi classified two distinct clinical phenotypes. These clusters had different TNFi drug survival, clinical characteristics, and disease activity.
format article
author Seulkee Lee
Seonyoung Kang
Yeonghee Eun
Hong-Hee Won
Hyungjin Kim
Hoon-Suk Cha
Eun-Mi Koh
Jaejoon Lee
author_facet Seulkee Lee
Seonyoung Kang
Yeonghee Eun
Hong-Hee Won
Hyungjin Kim
Hoon-Suk Cha
Eun-Mi Koh
Jaejoon Lee
author_sort Seulkee Lee
title A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
title_short A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
title_full A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
title_fullStr A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
title_full_unstemmed A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
title_sort cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics
publisher BMC
publishDate 2021
url https://doaj.org/article/dafb7014795240c296d53e36484abd95
work_keys_str_mv AT seulkeelee aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT seonyoungkang aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT yeongheeeun aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT hongheewon aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT hyungjinkim aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT hoonsukcha aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT eunmikoh aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT jaejoonlee aclusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT seulkeelee clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT seonyoungkang clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT yeongheeeun clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT hongheewon clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT hyungjinkim clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT hoonsukcha clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT eunmikoh clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
AT jaejoonlee clusteranalysisofpatientswithaxialspondyloarthritisusingtumournecrosisfactoralphainhibitorsbasedonclinicalcharacteristics
_version_ 1718419275380686848